Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
OUTCOMES STUDIED IN LEUKAEMIA CLINICAL TRIALS: A NEED FOR HARMONISATION?
- At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
- Type: Poster
- By: SAID, Dylan (University of Malta, Department of Pharmacy, Malta)
- Co-author(s): Dylan Said: Department of Pharmacy, University of Malta, Msida, Malta
John Joseph Borg: Malta Medicines Authority, San Ġwann, Malta
Maresca Attard Pizzuto: Department of Pharmacy, University of Malta, Msida, Malta
Anthony Serracino-Inglott: Department of Pharmacy, University of Malta, Msida, Malta
BackgroundSignificant inconsistency in outcomes reported in cancer clinical trials (CTs) is documented, which presents as a barrier to evidence synthesis, increasing the complexity of regulatory, policy and healthcare decision-making.
MethodsInterventional Phase II to Phase IV CTs investigating the main leukaemia subtypes acute lymphoblastic.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019